Is it safe to use a TENS unit for pain relief in a patient with atrial fibrillation, and what precautions should be taken?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

TENS Unit Use in Atrial Fibrillation: Safety Considerations

TENS units can be used cautiously in patients with atrial fibrillation who do not have implanted cardiac devices (pacemakers or ICDs), but are contraindicated or require specialized testing in those with such devices.

Key Safety Distinction

The critical factor determining TENS safety in AF patients is the presence or absence of implanted cardiac devices, not the atrial fibrillation itself.

For AF Patients WITHOUT Implanted Devices

TENS is generally safe with these precautions:

  • ECG artifact is the primary concern - TENS can create electrical signals that mimic cardiac arrhythmias on monitoring equipment 1, 2
  • The artifact can simulate atrial flutter or pacemaker spikes, potentially leading to misdiagnosis 1, 2
  • Remove TENS electrodes before ECG monitoring to avoid misinterpretation
  • TENS does not directly interfere with cardiac rhythm in patients without devices
  • Standard pain management protocols can proceed

For AF Patients WITH Implanted Devices (Critical)

TENS is contraindicated or requires device specialist supervision due to electromagnetic interference (EMI):

Evidence of Device Interference

Recent 2023 data shows EMI occurred in 15.9% of ICD patients tested with TENS 3:

  • Misinterpretation as ventricular tachycardia/fibrillation in 1.9% (could trigger inappropriate shocks)
  • Noise reversion causing temporary asynchronous pacing in 2.8%
  • False detection of premature beats in 14%

Risk factors for interference include 3:

  • Chest electrode placement (higher risk than other locations)
  • Higher current intensity settings
  • Device manufacturer variations

Older Studies Show Higher Risk

A 2008 study found more concerning interference rates 4:

  • 27% had signals interpreted as VT/VF
  • 47% showed false ventricular premature beats
  • Potential for both inappropriate shocks AND failure to deliver needed therapy

Critical caveat: Even if initial testing shows no interference, delayed interaction can occur. One case report documented normal testing immediately post-implant, but interference developed 6 months later with pacemaker-dependent bradycardia 5.

Clinical Algorithm

Step 1: Determine if patient has implanted cardiac device

  • If NO → Proceed to Step 2
  • If YES → Do not use TENS without cardiology consultation

Step 2: For patients without devices

  • Apply TENS per standard protocols
  • Avoid electrode placement during cardiac monitoring
  • Educate patient about ECG artifact if hospitalized

Step 3: For patients with devices who require TENS

  • Mandatory testing under cardiac device specialist supervision 3
  • Test at intended electrode positions and intensities
  • Document device interrogation before and after
  • Continuous monitoring during initial use
  • Avoid if patient is pacemaker-dependent (higher risk)

Common Pitfalls

  • Assuming modern devices are immune: While newer ICDs have improved filtering 3, EMI still occurs in 16% of patients with contemporary devices
  • One-time testing provides false reassurance: Device interaction can develop over time 5
  • Ignoring electrode position: Chest placement carries significantly higher risk than peripheral sites 3

Bottom Line

The atrial fibrillation itself does not contraindicate TENS use. However, many AF patients have implanted devices for rate control or arrhythmia management 6. Always verify device status before TENS application. For device patients requiring pain management, consider alternative modalities or proceed only with specialized cardiac monitoring.

References

Research

Transcutaneous electrical nerve stimulator-induced electrocardiogram artifact. A brief report.

American journal of physical medicine & rehabilitation, 1996

Research

Risk of occurrence of electromagnetic interference from the application of transcutaneous electrical nerve stimulation on the sensing function of implantable defibrillators.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023

Research

The simultaneous use of a biventricular implantable cardioverter defibrillator (ICD) and transcutaneous electrical nerve stimulation (TENS) unit: implications for device interaction.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.